Inform Diagnostics, an Irving, Texas-based pathology laboratory company, has agreed to pay $63.5 million to resolve allegations it violated the False Claims Act, Stark Law and the Anti-Kickback Statute, according to the Department of Justice.
The settlement resolves allegations that Inform violated the Anti-Kickback Statute and Stark Law by giving referring physicians subsidies for EHR systems and free or discounted technology consulting services.
The allegations against Inform were originally brought in three lawsuits filed under the qui tam, or whistle-blower, provision of the False Claims Act.
Inform was a subsidiary of Miraca Holdings, a Japanese company, and was named Miraca Life Sciences during the period relevant to the case. It was renamed in 2017 when majority ownership of the company changed, according to the Justice Department.
More articles on legal and regulatory issues:
8 latest healthcare industry lawsuits, settlements
Judge rejects attorney general's attempt to block sale of 2 California hospitals
Ex-CEO gets 46 months in prison for defrauding Florida hospital